Compare ARK Genomic Revolution ETF (ARKG) vs Deere & Company (DE) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Deere & Company — how do they compare? ARK Genomic Revolution ETF trades at $41, while Deere & Company trades at $586.86 (market cap $158.42B). The key difference: Deere & Company pays a 1.1% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Deere & Company nearer its low. Which is the better fit depends on your goals.
| ARKG | DE | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $662.49 |
52-Week Low | $23.09 | $439.11 |
Market Cap | — | $158.42B |
Enterprise Value | — | $213.24B |
Dividend Yield | — | 1.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Deere & Company (DE) trades at $586.86, down 1.02% on the day, near the lower end of its 52-week range. The stock shows a bullish technical signal with recent earnings beats but faces revenue declines from $60.2B in 2023 to $44.7B in 2025. Analyst consensus is mixed with a $689.30 price target, and the company maintains strong cash flow from operations of $7.46B in 2025.
The outlook hinges on agricultural sector recovery and precision farming growth, offering potential upside if earnings stabilize. Risks include cyclical demand, high debt levels, and margin pressure from declining net income. Investor sentiment is cautious amid volatile farm economics, yet institutional holdings suggest long-term confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Read more on DE →
